{"symbol":"BMY","fiscalQuarter":"Q4-2016","reportDate":"2017-01-26","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q4-2016","postBrief":{"headline":"Bristol Myers Squibb Misses on EPS \u2014 Stock Down 5.5%","keyNumbers":[{"metric":"EPS","actual":"$0.63","expected":"N/A","surprise":"-4.26%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management acknowledged challenges in the current market environment.","They emphasized a focus on long-term growth despite short-term hurdles."],"summary":"Management expressed concern over recent performance metrics. They reiterated their commitment to navigating market challenges."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Bristol Myers Squibb's earnings report indicates a slight miss on EPS expectations, contributing to a notable stock decline of 5.5%. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. The defensive tone from management suggests they are aware of the challenges ahead and are focusing on long-term strategies.","metaDescription":"Bristol Myers Squibb (BMY) Q4 2016 earnings: EPS missed. Stock down 5.5%. Full breakdown."}}